2Mullol J, Valero A, Alobid I, et al. Allergic rhinitis and its impact on asthma update (ARIA 2008). The perspective from Spain[J]. J Investig Allergol Clin Immunol, 2008, 18(5): 327-334.
5Peng ZK, Naelerio RM, Norman PS, et al. Quantitative IgEand IgG-subclass responses during and after long-term ragweed immunotherapy[J]. J Allergy Clin Immtmol, 1992, 89(2): 519-529,.
8Muller U. Immunotherapy of allergic diseases: present and future [J]. Sebweiz Med Wochensehr, 1983, 113(52): 1982-1988.
9Slater JE, Pastor RW. The determination of equivalent doses of standardized allergen vaccines[J]. J Allergy Clin Immunol, 2000, 105(3): 468-474.
10Filep S, Tsay A, Vailes L, et al. A multi-allergen standard for the calibration of immunoassays: CREATE principles applied to eight purified allergens [J]. Allergy, 2011, 10(1111), 1398-9995.
8Bousquet J, Lockey R,Malling HJ,et al. Allergen immunotherapy therapeutic vaccines for allergic diseases[J]. World Health Organi zation. American academy of Allergy. Asthma and Immunology. Ann Allergy Asthma Irnmunol, 1998,81:401-405.
9Bodtger U, Linneberg A. Remission of allergic rhinitis: An 8- year observational study[J]. J Allergy Clin Immnnol, 2004, 114(6): 1384-1388.
8Taher YA, Henricks PA, van Oosterhout AJ. Allergen-specific subcuta- neous immunotherapy in allergic asthma: immunologic mechanisms and improvement [J]. Libyan J Med, 2010,5:1 - 11.
